Why Gradual Dose Escalation Matters for Safety and Success Rapid dose increases lead to severe gastrointestinal side effects including nausea, vomiting, and constipation that cause many people to discontinue treatment
The risk of eating disorders comorbid with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Eating smaller meals, avoiding greasy foods and maintaining fluid intake can make the adjustment period easier
The result could position the drug as a treatment for MASH, which currently only has one FDA approved treatment in the market, Madrigals resmetirom (rezdiffra) , which achieves resolution of MASH and improves fibrosis, but does not have the added benefits of weight loss and glycemic control
Nie mona zapomina o stosowaniu wysokiej klasy kremu przeciwsonecznego, na przykad o faktorze SPF50